These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14697874)

  • 1. Monoamine oxidases: molecular, pharmacological and neurotoxicological aspects. A tribute to Professor Merton Sandler.
    Neurotoxicology; 2004 Jan; 25(1-2):3-335. PubMed ID: 14697874
    [No Abstract]   [Full Text] [Related]  

  • 2. 90 years of monoamine oxidase: some progress and some confusion.
    Tipton KF
    J Neural Transm (Vienna); 2018 Nov; 125(11):1519-1551. PubMed ID: 29637260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
    Youdim MB; Bakhle YS
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S287-96. PubMed ID: 16402116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the disordered regulation of monoamine oxidase activity in pathological states and the regulatory role of the monoamine oxidases].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1986; (8):8-13. PubMed ID: 3532612
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tribulin--a novel endogenous monoaminoxidase inhibitor (dedicated to the memory of Merton Sandler)].
    Medvedev AR
    Vopr Med Khim; 1996; 42(2):95-103. PubMed ID: 9148606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead.
    Tipton KF; Davey GP; McDonald AG
    Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase and their inhibitors. Preface.
    Int Rev Neurobiol; 2011; 100():xi-xv. PubMed ID: 21971011
    [No Abstract]   [Full Text] [Related]  

  • 8. Abstracts from the symposium Monoamine oxidase and disease: prospects for therapy with reversible inhibitors. Paris, October 26-28, 1983.
    Encephale; 1983; 9(2 Suppl 1):1A-98A. PubMed ID: 6641619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors].
    BERNHEIMER H; BIRKMAYER W; HORNYKIEWICZ O
    Wien Klin Wochenschr; 1962 Aug; 74():558-9. PubMed ID: 13868185
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural aspects of monoamine oxidase and its reversible inhibition.
    Wouters J
    Curr Med Chem; 1998 Apr; 5(2):137-62. PubMed ID: 9481038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Specific Detection and Inhibition of Monoamine Oxidases and Their Applications in Central Nervous System Diseases.
    Shi R; Wu Q; Xin C; Yu H; Lim KL; Li X; Shi Z; Zhang CW; Qian L; Li L; Huang W
    Chembiochem; 2019 Jun; 20(12):1487-1497. PubMed ID: 30664830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases.
    Rahman T; Rahmatullah M
    Bioorg Med Chem Lett; 2010 Jan; 20(2):537-40. PubMed ID: 19969454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
    Sandler M; Glover V; Clow A; Jarman J
    Adv Neurol; 1993; 60():238-41. PubMed ID: 8420141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of the pharmacological effect of monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1984; (11):72-5. PubMed ID: 6396999
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoamine oxidase and its inhibition (author's transl)].
    Gérardy J
    J Pharm Belg; 1980; 35(2):133-42. PubMed ID: 7391926
    [No Abstract]   [Full Text] [Related]  

  • 17. A neuroscientific update on monoamine oxidase and its inhibitors.
    Schwartz TL
    CNS Spectr; 2013 Dec; 18 Suppl 1():25-32; quiz 33. PubMed ID: 24252505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydropapaveroline in Parkinson's disease and alcoholism: a look back in honor of Merton Sandler.
    Collins MA
    Neurotoxicology; 2004 Jan; 25(1-2):117-20. PubMed ID: 14697886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amine oxidases].
    Levy L
    Therapie; 1968; 23(5):1003-36. PubMed ID: 4883547
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular aspects of monoamine oxidase B.
    Ramsay RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():81-9. PubMed ID: 26891670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.